2023-05-02 16:21:04
Allurion swallowable gastric balloon for weight loss arrives in Brazil
A large part of the population has already tried to lose weight with more exercise or with a change in diet, but without success. For weight loss plans, many think of seeking help from a nutritionist while others consider bariatric surgery, but a large number of people are afraid of surgical intervention. In view of this, Allurion created the swallowable gastric balloon for weight loss. It is recommended for adults with a body mass index (BMI) of 30 to 40 in Brazil. It is present in 60 countries and has treated more than 100,000 patients worldwide.
Allurion’s gastric balloon does not require a surgical procedure.
Through a doctor’s office visit lasting 15 minutes, a capsule is swallowed without any surgery, endoscopy or anesthesia. Along with the balloon, patients receive nutritional, physical and mental support. They have access to the Allurion Virtual Care Suite, with the Allurion Connected Scale, Health Tracker and Mobile App all working together to provide remote patient monitoring, telehealth and secure provider messaging – all under one digital umbrella. Providers interact with their patients through Allurion Insights, an end-to-end patient management solution powered by Artificial Intelligence and Machine Learning.
“Overweight and obesity are major risk factors for a number of chronic diseases, including heart disease and stroke, which are now the leading causes of preventable death worldwide. It is still shocking to see how poorly understood this preventable condition is. The beginning of achieving our mission and ending obesity is to help patients stop feeling guilty, begin to understand this complex condition and find themselves empowered to take action once morest it. Obesity can be treated today with non-invasive and safe solutions”, comments Benoit Chardon, International Director of Allurion.
About Allurion
The Allurion company is dedicated to ending obesity. The Allurion Program is a 360-degree weight loss experience featuring the Allurion Gastric Balloon for weight loss and the Allurion Virtual Care Suite, including the Allurion Mobile App for patients, Allurion Insights for clinicians with the Iris AI Platform and Allurion devices Connected Scale and Health Tracker. The Allurion Virtual Care Suite is also now available to consumers separately from the Allurion Program (which comes with the gastric balloon) to help customize, monitor and manage weight loss therapy for patients and can be used regardless of their treatment plan: balloon gastric, surgical, medical or nutritional.
To learn more regarding Allurion, visit www.allurion.com and the Allurion Virtual Care Suite at www.allurion.com/virtual-care-suite.
Allurion is a trademark of Allurion Technologies, Inc. in the United States and in countries around the world.
Website:
1683123219
#Allurion #swallowable #gastric #balloon #arrives #Brazil
